baber/WOPTO huggingface dataset:
Patent DE-69410877-T2 (DE)
Inventor: HAEUSER HERBERT
IPC: E05B19/06
Filed: 1994-04-28
Granted: 1998-11-26
Abstract: The locking device consists of a key (2) and a lock cylinder (1), with a cylinder core (5) which is rotatable in a casing (3) and has an axially extending channel (16) for insertion of a key (2) which passes through plate-shaped tumblers (7) arranged axially in succession so as to be displaceable in the cylinder core (5) and, with bit stages provided on the key shank (13), locates these tumblers (7) in a position releasing the rotation of the cylinder core (5). The locating displacement movement of the tumbler plates (7) is designed as a rotational movement round the axis of the key shank (13), and its range is preferably limited by stops (21, 22). <IMAGE>
Patent DE-69417060-T2 (DE)
Inventor: TING PAULINE
IPC: A61K31/445
Filed: 1994-12-05
Granted: 1999-07-15
Abstract: Disclosed are compounds of Formula I:    <IMAGE>  (I)  or a pharmaceutically acceptable salt or solvate thereof, wherein: R4 is alkenyl, alkoxy, or -OH. Also disclosed are pharmaceutical compositions containing compounds of Formula I, methods for inhibiting tumor necrosis factor- alpha , and methods for treating septic shock, inflammation, or allergic disease.
Patent DE-69421184-T2 (DE)
Inventor: SELIGSOHN SHERWIN
IPC: B64B1/48
Filed: 1994-07-22
Granted: 2000-08-24
Abstract: A sub-orbital, high altitude communications system comprising at least two ground stations and at least one high altitude relay station. Each of the ground stations including means for sending and receiving telecommunications signals. The relay stations include means for receiving and sending telecommunications signals from and to said ground stations and from and to other relay stations. Means are provided for controlling the lateral and vertical movement of the relay stations so that a predetermined altitude and location of each of said relay stations can be achieved and maintained. Means are provided for receiving the relay stations so that they can be serviced for reuse.
Patent DE-69429012-T2 (DE)
Inventor: ARNTZEN CHARLES J
IPC: C12N15/09
Filed: 1994-12-09
Granted: 2002-08-22
Abstract: A method for transforming a Musa plant comprises:   a. wounding meristematic tissue from a Musa plant by microparticle bombardment to generate a wounded Musa plant tissue and to facilitate access of Agrobacterium tumefaciens to Musa plant cells competent for transformation and regeneration; b. applying to said wounded Musa plant tissue at least one transformation competent Agrobacterium tumefaciens to transform said Musa plant, wherein said at least one transformation competent Agrobacterium tumefaciens harbours at least one Ti plasmid and at least one virulence gene, wherein said at least one Ti plasmid comprises at least one genetically engineered T-DNA to effect transformation of said Musa plant; c. growing said transformed Musa plant for a sufficient time to identify the presence of chimeric features; d. producing nonchimeric tissue by dividing said transformed Musa plant into segments which have at least one meristem which can regenerate into an intact plant and which have cells that are uniformly transformed to produce nonchimeric tissue; and e. growing said nonchimeric tissue into a nonchimeric plant.
Patent DE-69434332-T2 (DE)
Inventor: GIBBS CRAIG S
IPC: A61P7/02
Filed: 1994-11-14
Granted: 2006-02-02
Abstract: Novel polypeptides (NPs) are provided which are capable of protein C activation without significant fibrinogen clotting activity, and vice versa. NPs having enhanced protein C activating properties in relation to fibrinogen clotting are useful in particular as anticoagulants and in screening for substances that agonize or antagonize this property and in diagnostic procedures to determine the status of patients' activated protein C-mediated anticoagulant pathway. Procoagulant NPs are useful to promote clotting in the course of therapy of solid tumors, as an impregnate for bandages, or in diagnostic assays. The NPs are produced in recombinant cell culture or by in vitro methods.
Patent DE-69528485-T2 (DE)
Inventor: AKASAKA KOZO
IPC: C07D295/02
Filed: 1995-03-22
Granted: 2003-08-14
Abstract: A biphenyl derivative represented by the following formula (I) or a pharmacologically acceptable salt thereof: <CHEM> wherein R<1> represents a hydrogen atom, a halogen atom, a hydroxyl group, an amino group, a lower alkyl group, a halogenated lower alkyl group, a lower alkoxy group, a halogenated lower alkoxy group, a lower alkoxyalkyl group, a lower alkoxyalkoxy group, an aryl group, an aralkyl group, a heteroaryl group, a heteroarylalkyl group, a halogenated heteroarylalkyl group, a cyano lower alkyl group, a hydroxy lower alkyl group, an amino lower alkyl group, a lower alkoxycarbonyl group, an aryloxycarbonyl group, a cyano group, a formyl group, a lower acyl group, an aralkylcarbonyl group, a cycloether group, an alkenyl group, an alkynyl group, a lower alkylsulfinyl group, a lower alkylsulfonyl group, a lower alkylaminosulfonyl group, an arylaminosulfonyl group, a lower alkylsulfonylamino group, a halogenated lower alkylsulfonylamino group or an arylsulfonylamino group; R<2> and R<3> may be the same or different from each other and each represents a hydrogen atom, a halogen atom, a lower alkyl group, a halogenated lower alkyl group, a lower alkoxy group, a halogenated lower alkoxy group or a cyano group; R<4> represents a hydrogen atom or a halogen atom; R<5> represents a hydrogen atom, a lower alkyl group, a halogenated lower alkyl group, a hydroxy lower alkyl group, a lower alkoxycarbonyl group or an aryloxycarbonyl group; and n is 0 or an integer of 1 to 3, which exhibits dopamine 2 receptor antagonism and/or serotonin 2 receptor antagonism, is clinically useful for treating and ameliorating mental disorders such as cerebrovascular disorder, aggressive behavior due to senile dementia, mental excitation, poriomania, delirium, hallucination, hyperkinesia, schizophrenia, emotional disturbance, depression, neurosis, psychophysiologic disorder and anxiety neurosis.
Patent DE-69529531-T2 (DE)
Inventor: DOMANIK A
IPC: G01N35/10
Filed: 1995-10-06
Granted: 2003-11-20
Abstract: The present invention relates to a method for verifying dispense of a fluid from a dispense nozzle, the method comprising the steps of: providing a source of electromagnetic radiation and a receiver of the electromagnetic radiation from the source of electromagnetic radiation, such that the flow of a fluid from the nozzle passes through a path of electromagnetic radiation from the source to the receiver; energizing the source such that the source produces electromagnetic radiation; illuminating the receiver with the electromagnetic radiation; generating with the receiver a first signal; setting a threshold based on the first signal; dispensing fluid from the dispense nozzle; obstructing the electromagnetic signal between the source and the receiver with the fluid dispensed from the dispense nozzle; generating with the receiver a second signal; comparing the threshold and the second signal substantially continuously to indicate start of a dispense of fluid from the dispense nozzle; generating with the receiver a third signal; comparing the third signal and the threshold to indicate finish of a dispense of fluid from the dispense nozzle; determining a first time period between generation of the second signal and generation of the third signal; determining a second time period of an expected temporal duration between start and finish of the dispense of fluid from the dispense nozzle; and comparing the first time period and the second time period to verify the dispense of fluid from the dispense nozzle.         .
Patent DE-69529916-T2 (DE)
Inventor: KIRLIN PETER S
IPC: C07F9/00
Filed: 1995-09-14
Granted: 2003-12-11
Abstract: Niobium and tantalum compounds suitable for use as chemical vapor deposition source reagents, and a process for depositing niobium- or tantalum-containing coatings using the compounds. The compounds have formulaM(OR1)x(R2-C(GH)-C-C(G)-R3)ywherein M is tantalum or niobium; G is oxygen or sulfur; and R1, R2, and R3 are independently selected hydrocarbyl, fluoroalkyl or alkoxy groups.
Patent DE-69532719-T2 (DE)
Inventor: KOIVU VESA
IPC: H04W24/00
Filed: 1995-11-06
Granted: 2005-02-10
Abstract: The invention relates to a cellular radio system for transmitting communication signals from the base to the base station controller. The system includes transmission units which are used for transmitting communication signals between base stations and the base station controller. The communication signals feed a base station specific identification message to the base station controller by utilizing a predetermined communication channel in response to the base station initialization process.
Patent DE-69532819-T2 (DE)
Inventor: PERSSON LARS
IPC: A61P43/00
Filed: 1995-09-15
Granted: 2005-02-03
Abstract: The present invention relates to derivatives of phosphorylated carbohydrates and pharmaceutical compositions comprising as a pharmaceutically active ingredient at least one of these compounds.
Patent DE-69614138-T2 (DE)
Inventor: STIFFLER J
IPC: G06F11/14
Filed: 1996-11-27
Granted: 2002-07-18
Abstract: A mechanism for maintaining a consistent, periodically updated state in main memory without constraining normal computer operation is provided, thereby enabling a computer system to recover from faults without loss of data or processing continuity. In this invention, a first computer includes a processor and input/output elements connected to a main memory subsystem including a primary element. A second computer has a remote checkpoint memory element, which may include one or more buffer memories and a shadow memory, which is connected to the main memory subsystem of the first computer. During normal processing, an image of data written to the primary memory element is captured by the remote checkpoint memory element. When a new checkpoint is desired (thereby establishing a consistent state in main memory to which all executing applications can safely return following a fault), the data previously captured is used to establish a new checkpointed state in the second computer. In case of failure of the first computer, the second computer can be restarted to operate from the last checkpoint established for the first computer. This structure and protocol can guarantee a consistent state in main memory, thus enabling fault-tolerant operation.
Patent DE-69624566-T2 (DE)
Inventor: BEASLEY M
IPC: A61P43/00
Filed: 1996-05-23
Granted: 2003-06-26
Abstract: The invention provides a method for treating a clinically significant decrease in appetite comprising administering a pharmaceutically effective amount of 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine.
Patent DE-69624922-T2 (DE)
Inventor: MALLEN BRIAN D
IPC: F02B75/02
Filed: 1996-02-29
Granted: 2003-07-31
Abstract: A method for reducing the exhaust pollution emissions in a sliding vane internal combustion engine. First, an ultra-lean fuel-air combination is thoroughly premixed, the fuel-air combination having an equivalence ratio less than about 0.60 and a dimensionless concentration fluctuation fraction below about 0.33. After being premixed, the ultra-lean fuel-air combination is inducted into a vane cell, compressed, and it is then combusted at a peak compression plateau. The combusted fuel-air combination is purged after an expansion cycle. The combusting of the fuel-air combination may be initiated by autoignition.
Patent DE-69632303-T2 (DE)
Inventor: HENNINK EVERHARDUS
IPC: A61K48/00
Filed: 1996-08-16
Granted: 2005-05-12
Abstract: PCT No. PCT/NL96/00324 Sec. 371 Date Jun. 30, 1997 Sec. 102(e) Date Jun. 30, 1997 PCT Filed Aug. 16, 1996 PCT Pub. No. WO97/07226 PCT Pub. Date Feb. 27, 1997The present invention to a synthetic transfection system comprising as a carrier a cationic, water dispersible polyphosphazene. In addition, it relates to a method for introducing DNA fragments in target cells, comprising contacting these DNA fragments with a polyphosphazene which is at least partially substituted with cationic substituents and subsequently contacting the obtained transfection system with target cells. Finally, the invention involves the use of a polyphosphazene which is at least partially substituted with cationic substituents as a transfection vehicle.
Patent DE-69637377-T2 (DE)
Inventor: JACOBS PAUL T
IPC: A61L2/18
Filed: 1996-10-23
Granted: 2008-12-04
Abstract: An apparatus and process for hydrogen peroxide vapor sterilization of medical instruments and similar devices make use of hydrogen peroxide vapor released from an inorganic hydrogen peroxide complex. The peroxide vapor can be released at room temperature and atmospheric pressure; however, the pressure used can be less than 50 torr and the temperature greater than 86 DEG C to facilitate the release of hydrogen peroxide vapor. Preferred hydrogen peroxide complexes for use in the invention include Na4P2O7.3H2O2 and KH2PO4.H2O2. The heating rate can be greater than 5 DEG C. Optionally, a plasma can be used in conjunction with the vapor. <IMAGE>
Patent DE-69716954-T2 (DE)
Inventor: HEINEN JOHAN
IPC: F16B12/46
Filed: 1997-01-08
Granted: 2003-07-24
Abstract: Modular furniture system comprising a number of panels and a number of connecting elements for connecting the panels to form a piece of furniture on their own, wherein the panels are provided with holes for connection with the connecting elements, wherein at least some of the panels have a thickness d and wherein the panels each have a width and length, the panels being provided with at least one series of holes extending in the longitudinal direction, the centre-to-centre distance of which being d, which series of holes is situated at a distance of 2d from the neighbouring longitudinal side of the panel in question and wherein the width of the panels complies with the relation 2 1/2d + n1 . 1 1/2d, in which n,  ELEMENT  N0.
Patent DE-69721914-T2 (DE)
Inventor: GEURTS JORIS
IPC: G01C21/00
Filed: 1997-02-25
Granted: 2003-12-24
Abstract: A storage medium (202) carries data structures (220-222) with attribute values (224-232) for a plurality of geographical locations. On the basis of a given code the storage medium is accessed by a system in order to read the attribute values of the data structure (222) corresponding to the given code. The storage medium in accordance with the invention stores a structure description (236) which specifies the layout of the data structure (222) in attribute values. The system consults this structure description and, as a result, knows the layout of the relevant data structure. By storing the structure description on the storage medium different data structures with an individual more suitable layout can be stored. Moreover, a subsequent version of the storage medium can store an adaptation of the data structure layout while it can still be read by the original system.
Patent DE-69726206-T2 (DE)
Inventor: LAMBERT JOHN FRANCIS
IPC: A61P25/18
Filed: 1997-01-21
Granted: 2004-04-15
Abstract: The present invention relates to a pro-drug of ziprasidone or pharmaceutically acceptable salts thereof, processes for its preparation, and pharmaceutical compositions and methods of treatment comprising said pro-drug.
Patent DE-69730123-T2 (DE)
Inventor: HERRLEIN MATHIAS K
IPC: A61F13/15
Filed: 1997-06-25
Granted: 2005-08-18
Abstract: The present invention provides a new method for assessing disposable absorbent articles with regard to their impact on skin aeration by measuring relative humidity values in a mannequin test set up. <IMAGE>
Patent DE-69733752-T2 (DE)
Inventor: ADAMS E
IPC: A61K31/421
Filed: 1997-05-14
Granted: 2006-06-01
Abstract: Pharmaceutical compositions containing potassium, sodium or Tris salt of oxaprozin as an active agent. The pharmaceutical compositions of the present invention are useful in eliminating or ameliorating pain and in the treatment of inflammation and inflammation associated disorders such as rheumatoid arthritis and osteoarthritis.
Patent DE-69737289-T2 (DE)
Inventor: SUTTON S
IPC: A61B19/00
Filed: 1997-05-07
Granted: 2007-09-06
Abstract: An integrated optical biopsy forceps device and a method for tissue identification by optical analysis and biopsy sampling at a site within the body. The device includes an elongated catheter body for introduction into the body and navigation to an area of interest. An optical fiber extends through the device, from the proximal end, where it may be connected to electro-optical spectral analysis equipment, to a distal tip for illuminating and receiving light energy from tissue at the location of the tip. The distal end of the device has a pair of cutting jaws pivotally mounted at the distal end of the catheter body and controlled by control wires extending through the catheter body to a control handle at the proximal end, or by the optical fiber. The device may be spectroscopically guided to a site of interest within the body. The fiber tip is positioned coaxially with the jaws at the zone of contact and cutting of the jaws, and is retracted as the jaws close, so that the biopsy sample is taken exactly at the spot being viewed by the optical fiber.
Patent DE-69805335-T2 (DE)
Inventor: POZZATO GIANANTONIO
IPC: A61B18/12
Filed: 1998-06-18
Granted: 2002-11-28
Abstract: The invention realizes a radio knife powered by an electronic circuit that operates with high-frequency current wherein said circuit comprises: a rectifier circuit (20) fed by the mains voltage that supplies rectified pulsating voltage (201) to a radiofrequency circuit (30); a radiofrequency circuit (30) capable of emitting an output current signal (301) with a constant frequency in the scale of the MHz, powering the radio knife by means of a radiofrequency transformer (40). Said radiofrequency circuit (30) is obtained by piloting a MOSFET (305) through a pilot circuit (306) comprising a quartz-operated oscillator whose oscillation frequency amounts to at least twice the usual operating frequency of the MOSFET. The pilot circuit (306) is controlled by microprocessor current control circuit (310) that takes a signal proportional to the current from a current sensor (308) positioned after the MOSFET (305) and is such as to maintain the radiofrequency circuit current limited to a value compatible with the power that can be dissipated by the MOSFET independently of any variation in the circuit load impedance.
Patent DE-69812621-T2 (DE)
Inventor: MASCITELLI FRANCESCO
IPC: B05B11/00
Filed: 1998-09-30
Granted: 2004-02-05
Abstract: The present invention relates to a high dosage dispensing device or "dispenser", sealed both in the closed and in the open position. It comprises a body (1) connected at the bottom with a suction tube (2) and at the top with a ring nut (3), having internally a ball valve (4) and a spring-loaded stem (5). The stem (5) presents a ferrule (50) with sealing element, a plunger (6) and a dispensing spout (7). The ring nut (3) presents an opening delimited by an upwards-oriented lip, whilst the body (1) presents an upper terminal portion (15) comprising an edge (150) and a diameter disc (151). A check sleeve (9) inserted on the stem (5) is provided with an upper annular cuff (90) retained within an annular cavity (31) formed between the lip (30) and the edge (150). <IMAGE>
Patent DE-69815051-T2 (DE)
Inventor: CERUTTI PIETRO
IPC: C23C8/34
Filed: 1998-10-09
Granted: 2004-04-08
Abstract: In a process suitable to give a direct protection against the corrosion of metallic pieces, a nitrogen diffusion area is realised on the outer layer with a maximum depth of 0.1 mm, and with a nitrogen weight % lower than 2-4%, depending on the steel to he treated. The nitrogen is diffused into the piece and fills the imperfections and the empty areas of the crystal lattice. The temperature at which this first phase takes place goes from 480 to 525 DEG C depending from the steel type and the maximum duration is of 10 hours. Then, both the temperature values and the gas mixture, by introducing an oxidising atmosphere, are changed and the nitrogen diffusion is fully stopped by the oxygen action of the oxidising atmosphere against the iron atoms of the surface. Layers of Fe3O4 at 95-99% content are obtained, practically FeO/Fe2O3 oxides free, which are formed at temperatures comprised between 505 and 545 DEG C and which are comprised between 2 and 4  mu m and containing an oxygen weight % between 25% and 30%. A strong barrier and insulation effect is thereby obtained directly within the steel.
Patent DE-69815129-T2 (DE)
Inventor: RUSERT R
IPC: B65D30/06
Filed: 1998-09-17
Granted: 2004-04-08
Abstract: The present invention provides an improved open mesh bag comprising an open, mesh-like fabric. The bag has a closed end formed by a fold in the fabric, an opposing end and longitudinal, heat-sealed side seams extending from the closed end to the opposing end. The bags are used for packaging articles for which visibility and/or breathability of the bag fabric are useful characteristics. In a preferred embodiment, the bags are also suited for manufacture and filling using high speed, automated equipment.
Patent DE-69836487-T2 (DE)
Inventor: COSGROVE M
IPC: A61B19/00
Filed: 1998-02-18
Granted: 2007-03-15
Abstract: A minimally invasive approach for surgery on portions of the heart and great vessels. A parasternal incision is made extending across a predetermined number of costal cartilages, e.g., a right parasternal incision extending from the lower edge of the second costal cartilage to the superior edge of the fifth costal cartilage. One or more costal cartilages, e.g., the third and fourth, are then excised to provide access to the portion of the heart or great vessels of interest, for example between a point approximately three centimeters above supra annular ridge and the mid ventricular cavity, and a desired procedure completed. A minimally invasive procedure for repair or replacement of the aortic valve is disclosed that includes making a transverse incision of about 10 cm in length over the second or third intercostal space in the thorax of the patient, dividing the sternum transversely following the incision, retracting the transversely divided sternum, exposing the ascending aorta, and incising the ascending aorta to provide access to an area adjacent the aortic valve.
Patent DE-69901449-T2 (DE)
Inventor: RUSSAT JEAN
IPC: H03C1/60
Filed: 1999-07-08
Granted: 2002-11-21
Abstract: An analogue phase shifter with vector modulator is envisioned. The analogue phase shifter has an input stage that provides the generation of a pseudo-basis of four vectors. The analogue phase shifter has a multiphase filter. The analogue phase shifter has an output stage that controls the amplitde of the basis vectors, and acts to recombine them. The input stase is made with a phase opposition signal generator and a multiphase filter. The input stase is made of four variable attenuators. The attenuators are for separate control of the amplitude of each of the basis vectors. The output stage also has a common output providing the summation of four quadrature channels. In one case, the output stage includes two differential amplifiers. In another case the quadrature channels are connected to the common output through buffer amplifier stages, each followed by a summation capacitor.
Patent DE-69912909-T2 (DE)
Inventor: RENKENS ANNEMARIE JOHANNA MARI
IPC: A23L27/30
Filed: 1999-09-21
Granted: 2004-04-15
Abstract: The invention relates to a sweetener composition based on a combination of saccharin, cyclamate and thaumatin, comprising:     5 - 10 parts by weight of saccharin and/or sodium saccharin,   50 - 100 parts by weight of sodium cyclamate,   0.001 - 0.1 parts by weight of thaumatin, wherein the weight ratio of sodium cyclamate to saccharin and/or sodium saccharin is between 8 and 15.